Spears Abacus Advisors LLC Amgen Inc Transaction History

Spears Abacus Advisors LLC

$4.73 Billion
Q3 2024

A detailed history of Spears Abacus Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Spears Abacus Advisors LLC holds 13,855 shares of AMGN stock, worth $3.88 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

13,855

Previous 13,686 1.23%

Holding current value

$3.88 Million

Previous $4.28 Million 4.4%

% of portfolio

0.09%

Previous 0.09%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$309.38 - $337.38 $52,285 - $57,017	169 Added 1.23%	13,855 $4.46 Million
Q2 2024 Aug 12, 2024	BUY	$262.75 - $319.31 $587,246 - $713,657	2,235 Added 19.52%	13,686 $4.28 Million
Q1 2024 May 10, 2024	BUY	$268.87 - $324.56 $2.17 Million - $2.62 Million	8,086 Added 240.3%	11,451 $3.26 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $509,319 - $602,260	2,377 Added 240.59%	3,365 $747,000
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $44,254 - $53,939	-196 Reduced 16.55%	988 $238,000
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $24,466 - $27,593	-109 Reduced 8.43%	1,184 $267,000
Q2 2022 Aug 08, 2022	SELL	$230.71 - $256.74 $85,131 - $94,737	-369 Reduced 22.2%	1,293 $315,000
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $592,029 - $654,939	-2,700 Reduced 61.9%	1,662 $402,000
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $450,662 - $515,741	2,266 Added 108.11%	4,362 $981,000
Q2 2021 Aug 09, 2021	BUY	$233.58 - $259.14 $489,583 - $543,157	2,096 New	2,096 $511,000
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $417,397 - $497,045	-1,929 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $452,639 - $503,372	1,929 New	1,929 $490,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Spears Abacus Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spears Abacus Advisors LLC with notifications on news.

Account

Spears Abacus Advisors LLC Amgen Inc Transaction History